Call Options Transactions Made in Q1 2023 in Ambrx Biopharma Inc. (AMAM)
This table provides information about the institutional ownership of Ambrx Biopharma Inc. (AMAM) during Q1 2023. The information is specifically focused on institutions that hold call options of Ambrx Biopharma Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Toms Capital Investment Management LP
New York, NY |
BUY
|
CALL |
1MNew |
$1.46M - $12.5M
|
1M
$28M
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
CALL |
199KNew |
$290K - $2.49M
|
199K
$5.57M
|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
114KNew |
$166K - $1.43M
|
114K
$3.19M
|
|
May 12, 2023
Q1 2023
|
Hap Trading, LLC
New York, NY |
BUY
|
CALL |
32.4KNew |
$47.3K - $406K
|
32.4K
$907K
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
28.2K+ 233.06% |
$41.2K - $354K
|
40.3K
$1.13M
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
20KNew |
$29.2K - $251K
|
20K
$560K
|
|
May 15, 2023
Q1 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
15.2KNew |
$22.2K - $191K
|
15.2K
$426K
|
|
May 01, 2023
Q1 2023
|
Cutler Group LP
|
BUY
|
CALL |
2.4K+ 25.53% |
$3.5K - $30.1K
|
11.8K
$330K
|